Genetics Unit, Mauro Baschirotto Institute for Rare Diseases-B.I.R.D. Foundation, Costozza di Longare, Vicenza, Italy.
J Mol Neurosci. 2011 Mar;43(3):346-9. doi: 10.1007/s12031-010-9448-4. Epub 2010 Sep 18.
Autosomal recessive spastic ataxia of Charlevoix-Saguenay, more commonly known as ARSACS, is an early-onset cerebellar ataxia with spasticity, amyotrophy, nystagmus, dysarthria, and peripheral neuropathy. SACS is the only gene known to be associated with the ARSACS phenotype. To date, 55 mutations have been reported; of these, only five in Italian patients. We found two novel homozygous nonsense mutations in the giant exon of SACS gene in two unrelated patients with classical ARSACS phenotype. Characterization of the homozygous nature of the mutations through genotyping of the parents, quantitative DNA analysis and indirect STS studies permitted us to confirm in one of the cases that uniparental isodisomy of the paternal chromosome 13 carrying the mutated SACS gene played an etiologic role in the disease.
常染色体隐性痉挛性共济失调型小脑性共济失调(也称为 ARSACS)是一种早发性小脑共济失调,伴有痉挛、肌萎缩、眼球震颤、构音障碍和周围神经病。SACS 是唯一已知与 ARSACS 表型相关的基因。迄今为止,已经报道了 55 种突变;其中只有 5 种在意大利患者中发现。我们在 2 位具有典型 ARSACS 表型的非相关患者中发现了 SACS 基因的巨大外显子中的两个新的纯合无义突变。通过对父母的基因分型、定量 DNA 分析和间接 STS 研究对突变的纯合性质进行分析,使我们能够在其中一个病例中确认携带突变 SACS 基因的父 13 号染色体单亲二体性在疾病中起病因作用。